Circulating tumour cells in prostate cancer
Authors:
- 6 March 2018
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Urology
- Vol. 15 (5) , 265-266
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor CellsClinical Chemistry, 2018
- Analogous detection of circulating tumor cells using the AccuCyte®—CyteFinder® system and ISET system in patients with locally advanced and metastatic prostate cancerThe Prostate, 2017
- Epithelial-mesenchymal plasticity in circulating tumor cellsJournal of Molecular Medicine, 2016
- Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patientsScientific Reports, 2016
- EMT, cell plasticity and metastasisCancer and Metastasis Reviews, 2016
- EMT: 2016Cell, 2016
- Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid BiopsyCancer Discovery, 2016
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate CancerNew England Journal of Medicine, 2014
- Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequencesCellular and Molecular Life Sciences, 2014
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate CancerClinical Cancer Research, 2008